Overview

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The patients are being followed in this study to determine the safety of taking the medication Duloxetine for a long period of time. The patients participating in this study suffer from Stress Urinary Incontinence.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride